Agenus Inc.
NASDAQ: AGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Employees
- 316
- Headquarters
- Lexington, United States
- IPO year
- 2000
- Market cap
- $121.6M
- Website
- https://www.agenusbio.com
Loading AGEN…
Loading profile data…Frequently asked questions about AGEN
What does Agenus Inc. (AGEN) do?
Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside oth...
Where does AGEN trade?
Agenus Inc. (AGEN) trades on the NASDAQ Capital Market.
What sector is AGEN in?
Agenus Inc. (AGEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Agenus Inc.?
Garo H. Armen is the chief executive officer of Agenus Inc. (AGEN).
Where is Agenus Inc. headquartered?
Agenus Inc. is headquartered in United States.
Does AGEN pay a dividend?
Agenus Inc. (AGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AGEN go public?
Agenus Inc. (AGEN) completed its initial public offering in 2000.